GILD
Options analysis and insights • Healthcare
$134.25
GILD is currently showing subdued IV Rank of 46.4%, with relatively cheap options. The RSI at 36 indicates bearish momentum zone. Price action shows no clear directional bias.
IV Rank
46%
RSI (14)
36
Trend Bias
neutral
Implied Volatility Rank
Normal range
IV Rank compares current implied volatility to its 52-week range. Lower IV may present opportunities for volatility buyers.
What This Means
Moderate IV Rank (46%) means options are fairly priced compared to historical norms. Neither buyers nor sellers have a clear edge from volatility alone. The neutral trend structure indicates no clear direction. Price may consolidate or wait for a catalyst. The recommended Covered Calls strategy fits the current conditions because it aligns with the neutral trend and lower volatility environment.
Sector Context
Within the Healthcare sector, GILD trades alongside peers like JNJ, UNH, PFE. GILD's IV Rank is in line with Healthcare sector norms. Comparing volatility and trend structure across sector peers can reveal relative value opportunities.
Recommended Strategy
covered Call
Suitability Score
IV Rank at 46% with neutral trend. Ideal for income generation while holding shares.
Market Conditions
Trend Structure
Dealer Positioning
Frequently Asked Questions
What is GILD's current IV Rank?
GILD's IV Rank is currently 46.4%, which is subdued compared to its 52-week range.
When is GILD's next earnings report?
GILD does not have an imminent earnings date on the calendar.
What options strategy is best for GILD right now?
Based on current market conditions, Covered Calls is the top recommendation. IV Rank at 46% with neutral trend. Ideal for income generation while holding shares.
Is GILD IV high or low?
GILD's 30-day implied volatility is 33.5%, with an IV Rank of 46.4%. This places current IV toward the lower end of its annual range.
Explore Strikium Features
Smart Scanners
Discover high IV opportunities, earnings plays, and unusual activity
Volatility Analysis
IV rank trends, term structure, and historical comparisons
GEX & Strategy
Gamma exposure levels and data-driven strategy recommendations